Circulating Microparticle Subpopulation in Metabolic Syndrome: Relation to Oxidative Stress and Coagulation Markers

Overview

Journal Diabetes Metab Syndr Obes

Publisher Dove Medical Press

Specialty Endocrinology

Date 2019 May 3

PMID 31043798

Citations 8

Authors

Asmaa M Zahran

Sohair K Sayed

Heba A Abd El Hafeez

Walaa A Khalifa

Nahed A Mohamed

Helal F Hetta

Affiliations

Soon will be listed here.

Abstract

Background: Circulating microparticles (MPs) contribute to the pathogenesis of atherothrombotic disorders and are raised in cardiovascular diseases. Herein, we aimed to investigate the effect of moderate metabolic abnormalities in an early stage of metabolic syndrome (MetS) on the level of MP subpopulations and to study relationships between MP subpopulations and both oxidative stress and coagulation markers.

Methods: Flow cytometry used to evaluate circulating MPs subpopulations in 40 patients with an early stage MetS and 30 healthy controls. ELISA was used to quantify plasminogen activator inhibitor type 1/tissue plasminogen activator (PAI-1/TPA) while plasma glutathione peroxidase (GPx) activity was measured spectrophotometrically.

Results: Total MPs were significantly elevated in MetS (<0.001). Glutathione peroxidase and PAI1/TPA activity was significantly increased in subjects with MetS (<0.001). Waist circumference, diastolic blood pressure, and total cholesterol positively influenced levels of total MPs, platelet-derived microparticles, and endothelium-derived microparticles. Fasting blood glucose, cholesterol, triglycerides, and low-density lipoprotein positively influenced the coagulation factors (TPA, PAI1). However, high-density lipoprotein negatively influenced platelet-derived MPs and factors associated with fibrinolysis (TPA, PAI1).

Conclusion: Elevated circulating MPs are associated with MetS abnormalities, oxidative stress and coagulation factors and may act as early predictor of metabolic syndrome with risk of cardiovascular disease.

Citing Articles

Insulin Resistance-Induced Platelet Hyperactivity and a Potential Biomarker Role of Platelet Parameters: A Narrative Review.

Kelem A, Adane T, Shiferaw E Diabetes Metab Syndr Obes. 2023; 16:2843-2853.

PMID: 37744701 PMC: 10516192. DOI: 10.2147/DMSO.S425469.

Circulating Extracellular Vesicles Are Strongly Associated With Cardiovascular Risk Markers.

Zhou R, Bozbas E, Allen-Redpath K, Yaqoob P Front Cardiovasc Med. 2022; 9:907457.

PMID: 35694679 PMC: 9178174. DOI: 10.3389/fcvm.2022.907457.

Diets and Cellular-Derived Microparticles: Weighing a Plausible Link With Cerebral Small Vessel Disease.

Che Mohd Nassir C, Ghazali M, Hashim S, Idris N, Yuen L, Hui W Front Cardiovasc Med. 2021; 8:632131.

PMID: 33718454 PMC: 7943466. DOI: 10.3389/fcvm.2021.632131.

Processing methods and storage duration impact extracellular vesicle counts in red blood cell units.

Gamonet C, Desmarets M, Mourey G, Biichle S, Aupet S, Laheurte C Blood Adv. 2020; 4(21):5527-5539.

PMID: 33166402 PMC: 7656935. DOI: 10.1182/bloodadvances.2020001658.

Current Approaches Targeting the Wound Healing Phases to Attenuate Fibrosis and Scarring.

El Ayadi A, Jay J, Prasai A Int J Mol Sci. 2020; 21(3).

PMID: 32046094 PMC: 7037118. DOI: 10.3390/ijms21031105.

References

Neil Thomas G, Ho S, Janus E, Lam K, Hedley A, Lam T . The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population. Diabetes Res Clin Pract. 2005; 67(3):251-7. DOI: 10.1016/j.diabres.2004.07.022. View

Johnson W, Kroon J, Greenway F, Bouchard C, Ryan D, Katzmarzyk P . Prevalence of risk factors for metabolic syndrome in adolescents: National Health and Nutrition Examination Survey (NHANES), 2001-2006. Arch Pediatr Adolesc Med. 2009; 163(4):371-7. DOI: 10.1001/archpediatrics.2009.3. View

Roberts C, Sindhu K . Oxidative stress and metabolic syndrome. Life Sci. 2009; 84(21-22):705-12. DOI: 10.1016/j.lfs.2009.02.026. View

Nasreddine L, Ouaijan K, Mansour M, Adra N, Sinno D, Hwalla N . Metabolic syndrome and insulin resistance in obese prepubertal children in Lebanon: a primary health concern. Ann Nutr Metab. 2010; 57(2):135-42. DOI: 10.1159/000321532. View

Asselbergs F, Williams S, Hebert P, Coffey C, Hillege H, Navis G . Epistatic effects of polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels. Genomics. 2007; 89(3):362-9. PMC: 1808222. DOI: 10.1016/j.ygeno.2006.11.004. View

Coffey C, Asselbergs F, Hebert P, Hillege H, Li Q, Moore J . The Association of the Metabolic Syndrome with PAI-1 and t-PA Levels. Cardiol Res Pract. 2011; 2011:541467. PMC: 3087975. DOI: 10.4061/2011/541467. View

Anand S, Yi Q, Gerstein H, Lonn E, Jacobs R, Vuksan V . Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation. 2003; 108(4):420-5. DOI: 10.1161/01.CIR.0000080884.27358.49. View

Goichot B, Grunebaum L, Desprez D, Vinzio S, Meyer L, Schlienger J . Circulating procoagulant microparticles in obesity. Diabetes Metab. 2006; 32(1):82-5. DOI: 10.1016/s1262-3636(07)70251-3. View

Agirbasli M, Agaoglu N, Ergonul O, Yagmur I, Aydogar H, Oneri T . Comparison of anthropometric indices in predicting metabolic syndrome components in children. Metab Syndr Relat Disord. 2011; 9(6):453-9. DOI: 10.1089/met.2011.0018. View

10.

Ahmadi A, Leipsic J, Feuchtner G, Gransar H, Kalra D, Heo R . Is metabolic syndrome predictive of prevalence, extent, and risk of coronary artery disease beyond its components? Results from the multinational coronary CT angiography evaluation for clinical outcome: an international multicenter registry (CONFIRM). PLoS One. 2015; 10(3):e0118998. PMC: 4348482. DOI: 10.1371/journal.pone.0118998. View

11.

Xu M, Wu X, Zhou Y, Xue Y, Zhang K . Proteomic characteristics of circulating microparticles in patients with newly-diagnosed type 2 diabetes. Am J Transl Res. 2016; 8(1):209-20. PMC: 4759430. View

12.

Shantsila E . Endothelial microparticles: a universal marker of vascular health?. J Hum Hypertens. 2008; 23(5):359-61. DOI: 10.1038/jhh.2008.138. View

13.

Zaghloul A, Al-Bukhari T, Al-Pakistani H, Shalaby M, Halawani S, Bajuaifer N . Soluble endothelial protein C receptor and high sensitivity C reactive protein levels as markers of endothelial dysfunction in patients with type 1 and type 2 diabetes mellitus: their role in the prediction of vascular complications. Diabetes Res Clin Pract. 2014; 106(3):597-604. DOI: 10.1016/j.diabres.2014.09.007. View

14.

Agouni A, Lagrue-Lak-Hal A, Ducluzeau P, Mostefai H, Draunet-Busson C, Leftheriotis G . Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. Am J Pathol. 2008; 173(4):1210-9. PMC: 2543087. DOI: 10.2353/ajpath.2008.080228. View

15.

Hekmatdoost A, Mirmiran P, Hosseini-Esfahani F, Azizi F . Dietary fatty acid composition and metabolic syndrome in Tehranian adults. Nutrition. 2011; 27(10):1002-7. DOI: 10.1016/j.nut.2010.11.004. View

16.

Wilson P, DAgostino R, Parise H, Sullivan L, Meigs J . Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005; 112(20):3066-72. DOI: 10.1161/CIRCULATIONAHA.105.539528. View

17.

Bouguerra R, Alberti H, Smida H, Salem L, Rayana C, El Atti J . Waist circumference cut-off points for identification of abdominal obesity among the tunisian adult population. Diabetes Obes Metab. 2007; 9(6):859-68. DOI: 10.1111/j.1463-1326.2006.00667.x. View

18.

Berezin A, Kremzer A, Martovitskaya Y, Samura T, Berezina T . The predictive role of circulating microparticles in patients with chronic heart failure. BBA Clin. 2015; 3:18-24. PMC: 4661507. DOI: 10.1016/j.bbacli.2014.11.006. View

19.

Gierach M, Gierach J, Ewertowska M, Arndt A, Junik R . Correlation between Body Mass Index and Waist Circumference in Patients with Metabolic Syndrome. ISRN Endocrinol. 2014; 2014:514589. PMC: 3960736. DOI: 10.1155/2014/514589. View

20.

Lijnen H . Pleiotropic functions of plasminogen activator inhibitor-1. J Thromb Haemost. 2005; 3(1):35-45. DOI: 10.1111/j.1538-7836.2004.00827.x. View